Circulation

FEBRUARY 12, 2024

Circulation, Ahead of Print. The secondary outcomes included ischemia-driven target lesion revascularization, target vessel myocardial infarction, death, cardiac death, target vessel revascularization, stent thrombosis, and major adverse cardiac events. Frequentist random-effects network meta-analyses were conducted.

Ultrasound 67

Ultrasound Myocardial Infarction Thrombosis Stents 67

Circulation

OCTOBER 24, 2023

Circulation, Ahead of Print. Background:Stopping aspirin within 1 month after implantation of a drug-eluting stent (DES) for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome (ACS). versus 3.4%; HR, 0.35 [95% CI, 0.20–0.61];P<0.001).Conclusions:This 0.61];P<0.001).Conclusions:This

Stents 40

Stents Stent Myocardial Infarction Thrombosis 40

DAIC

MARCH 8, 2024

As an alternative therapeutic option, LVAD heart pumps have been implanted to help patients with end-stage heart failure sustain blood circulation in the body. However, there are shortcomings associated with LVAD implantation: complications include infection, blood clotting (thrombosis), stroke and bleeding.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145424-A4145424, November 12, 2024. The outcome was any 30-day event defined as death, stent thrombosis, major bleeding events, and composites of ischemic and bleeding events. 41% patients were treated with immediate dual therapy, and 59% were discharged on triple therapy.

Thrombosis 40

Thrombosis Outcomes Stents Stent 40

Circulation: Cardiovascular Interventions

MARCH 30, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. Endpoints included major adverse cardiovascular events (MACE), cardiac death, myocardial infarction (MI), periprocedural MI, all-cause mortality, stent thrombosis (definite or probable), and target vessel revascularization (TVR). 0.76; p=0.003), MI (RR 0.75; 95%CI 0.59-0.96;

Thrombosis 40

Thrombosis Myocardial Infarction Stents Stent 40

Circulation

FEBRUARY 26, 2024

Circulation, Ahead of Print. The primary efficacy objective was to demonstrate superiority of PPA to reduce the primary efficacy end point of all-cause death, nonfatal myocardial infarction, nonfatal stroke, stent thrombosis (definite), or urgent revascularization (any vessel) within 30 days.

Myocardial Infarction 40

Myocardial Infarction Academic Thrombosis STEMI 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4132742-A4132742, November 12, 2024. vs 13.6%), any stent thrombosis (RR=1.42; 95% CI [0.35, 5.72]; p=0.62; 2.2% The pooled results of the 4 RCTs showed that MACE (RR=0.66; 95% CI [0.45, 0.99]; p=0.01; 16.8% vs 6.0%), stroke (RR=1.02; 95% CI [0.38, 2.75]; p =0.97; 2.0%

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Thrombosis 40

Cardiology Update

APRIL 9, 2024

The Impella CP is a catheter-based, axial flow pump that pumps blood directly from the left ventricle into the circulation. The primary non-inferiority endpoint was MACCE (a composite of cardiac death, MI, ischaemic stroke, stent thrombosis, or target vessel revascularisation). It is able to deliver 3.5L/min

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 6, 2025

In group II, circulating heparin was neutralized with a half dose of protamine sulfate, and the brachial sheath was removed immediately after the procedure.ResultsThere were no cases of acute stent thrombosis, nonfatal myocardial infarction or in-hospital mortality in either group.

Myocardial Infarction 52

Myocardial Infarction Thrombosis Stents Stent 52

AMS Cardiology

MARCH 20, 2025

Total loss of circulation can lead to gangrene and loss of a limb. Deep Vein Thrombosis (DVT) : A blood clot occurring in a deep vein. Causes include infection, malignancy, surgery, scar tissue formation, trauma, deep vein thrombosis (DVT), radiation or other cancer treatment. Damaged valves within the veins cause this.

Vascular Care 52

Vascular Care Blood Clot Aneurysm Peripheral Arterial Disease 52

Dr. Smith's ECG Blog

MARCH 8, 2025

After stent deployment, we often see improvement in the ST-T within seconds or minutes. Here is the final angiogram following placement of a stent in the ostial RCA. 2:04 PM, post stent deployment You can see that even after complete restoration of flow, the ECG still looks terrible, V most of all. Circulation , 92 (3), 657671.

Cardiomyopathy 75

Cardiomyopathy Myocardial Infarction Defibrillator Bradycardia 75